Naoe T - Search Results

1

Comparable profiles of the immunoglobulin heavy chain complementarity determining region (CDR)-3 in CD5+ and CD5- human cord blood B lymphocytes.

Kiyoi H, Naito K, Ohno R, Naoe T. Kiyoi H, et al. Among authors: naoe t. Immunology. 1995 Jun;85(2):236-40. Immunology. 1995. PMID: 7543877 Free PMC article.

2

Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone.

Ohashi H, Ichikawa A, Takagi N, Hotta T, Naoe T, Ohno R, Saito H. Ohashi H, et al. Among authors: naoe t. Leukemia. 1992 Aug;6(8):859-62. Leukemia. 1992. PMID: 1353552

3

Haemolytic uraemic syndrome during FK506 therapy.

Ichihashi T, Naoe T, Yoshida H, Kiyoi H, Fukutani H, Kubo K, Yamauchi T, Saito H, Ohno R. Ichihashi T, et al. Among authors: naoe t. Lancet. 1992 Jul 4;340(8810):60-1. doi: 10.1016/0140-6736(92)92482-u. Lancet. 1992. PMID: 1376852 No abstract available.

4

Development of hyperthyroidism in donor and recipient after allogeneic bone marrow transplantation.

Ichihashi T, Yoshida H, Kiyoi H, Fukutani H, Kubo K, Yamauchi T, Naoe T, Ohno R. Ichihashi T, et al. Among authors: naoe t. Bone Marrow Transplant. 1992 Oct;10(4):397-8. Bone Marrow Transplant. 1992. PMID: 1422500 No abstract available.

5

Effective treatment of adult T cell leukemia/lymphoma with a novel oral antitumor agent, MST-16.

Ichihashi T, Kiyoi H, Fukutani H, Kubo K, Yamauchi T, Naoe T, Yamada K, Ohno R. Ichihashi T, et al. Among authors: naoe t. Oncology. 1992;49(5):333-5. doi: 10.1159/000227067. Oncology. 1992. PMID: 1528567 Clinical Trial.

6

Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells.

Kiyoi H, Naoe T, Horibe K, Ohno R. Kiyoi H, et al. Among authors: naoe t. J Clin Invest. 1992 Mar;89(3):739-46. doi: 10.1172/JCI115650. J Clin Invest. 1992. PMID: 1541668 Free PMC article.

7

Disappearance of minimal residual lymphoblastic leukemia cells 6 months after allogeneic bone marrow transplantation without GVHD.

Kiyoi H, Naoe T, Kitamura K, Yamauchi T, Ichihashi T, Ohno R. Kiyoi H, et al. Among authors: naoe t. Bone Marrow Transplant. 1991 Jul;8(1):59-62. Bone Marrow Transplant. 1991. PMID: 1912956

8

Treatment of myelodysplastic syndromes with orally administered N-(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucine (ubenimex).

Fukutani H, Naoe T, Saito H, Ohshima T, Omine M, Miura Y, Mizoguchi H, Kimura I, Tomonaga M, Ohno R. Fukutani H, et al. Among authors: naoe t. Jpn J Clin Oncol. 1991 Aug;21(4):287-92. Jpn J Clin Oncol. 1991. PMID: 1942558 Clinical Trial.

9

New enzyme-linked immunosorbent assay for glycocalicin in plasma.

Kunishima S, Hayashi K, Kobayashi S, Naoe T, Ohno R. Kunishima S, et al. Among authors: naoe t. Clin Chem. 1991 Feb;37(2):169-72. Clin Chem. 1991. PMID: 1993320

10

[Is allogeneic bone marrow transplantation the first choice for acute leukemia in first remission? From chemotherapeutical point of view].

Fukutani H, Naoe T, Ohno R. Fukutani H, et al. Among authors: naoe t. Rinsho Ketsueki. 1991 Apr;32(4):361-5. Rinsho Ketsueki. 1991. PMID: 2067079 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters